sameAs
A landscape of driver mutations in melanomaDetection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry.Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels.Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma.Final trial report of sentinel-node biopsy versus nodal observation in melanoma.Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patientsEstrogen receptor-alpha methylation predicts melanoma progressionMicrophthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.Predictors of occult nodal metastasis in patients with thin melanoma.Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.Age as a prognostic factor in patients with localized melanoma and regional metastases.Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccineA 20-year experience of hepatic resection for melanoma: is there an expanding role?The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.Sentinel-node biopsy or nodal observation in melanoma.The role of sentinel lymph node biopsy in the management of melanomaSurgery for distant melanoma metastasis.Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanomaPrognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.Management decisions for nodal metastasis from an unknown primary melanomaManagement of popliteal sentinel nodes in melanoma.Immunotherapy of malignant melanoma.New TNM melanoma staging system: linking biology and natural history to clinical outcomes.Melanoma: is immunotherapy of benefit?Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cellsDoes metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.An evidence-based staging system for cutaneous melanoma.Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcomeEpitrochlear sentinel lymph nodes in melanoma: interval or independent?Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
P50
Q24603357-84821B4D-28C6-49D5-B855-6ED21ADE0D9AQ31092822-A9D6B4E5-5C0D-4082-ACDE-607D1DC0B64AQ33604057-77EA7577-0017-49A0-A22A-AABBB911903EQ33657979-D6023C99-4EC2-46B3-A152-0FED45EDA4B2Q33754941-8BE8C12F-BBB5-4650-81D8-82DF5008834EQ33760173-0F14E2B5-BFC2-4BFA-A231-5ABF20B40D6CQ33797051-50E36C42-8F17-4FC3-9035-D87E54DD752CQ33797076-A658A042-A56C-4984-85FC-C5DA855B0AD7Q33797088-870AFFDF-B816-419A-9183-F793ACB45BDEQ33887196-90CAA98C-002A-4386-B300-862D1CB52E4EQ33890196-A2BBB892-A2E8-47DF-BFEE-0C89862D3F36Q33893833-DD7B30CB-9863-4578-B467-7E4B1239DE8BQ34000266-1B40CD7D-95F8-47AF-ACA3-DAA80820A1AEQ34000273-D579711F-512C-4375-8A59-9E1EB87E4201Q34059854-64F05A46-03E4-42D1-8443-EAC44B370513Q34150440-2BC6548F-388A-4D84-9520-16942CED128CQ34268361-93AEEAA8-A896-4796-A669-9674CA7C7CADQ34286994-2E57A66A-EE17-4EAA-A4DC-49B9E7D31048Q34315676-62659E3F-D1C2-4AD5-A055-AADF22C5D732Q34550821-8B4DFADA-6714-488B-8B60-AB18BEC32556Q34571347-F315E457-050F-4795-9004-4166933E9A8DQ34584396-8FFD9A0B-A398-4162-BB4A-C3AE4BA318F0Q34636992-53A8BEDD-74F3-446C-87CD-E58F80DDB21CQ34713622-87526F53-F494-4491-A538-430E31A922D6Q35023404-D2C9EBE0-018C-4C3D-8540-C254B98647DFQ35047049-C0AA5821-81BF-420F-BA8F-5A961DB179D6Q35068833-D302934B-0307-4B71-A144-ACFB671E0E5CQ35126556-7C9ADF57-9159-45F4-8537-674D193953D3Q35201623-65B9CE93-B416-40A1-B1C2-30C97D950439Q35210885-B078E71D-6EE0-482D-BA3B-3C7BCD43C4A9Q35368001-138E687B-D6A8-4B1D-B3EC-D588C4FA98B2Q35422126-17B4D917-18F9-4173-A9C9-4BCEF66410F4Q35567949-EB1126BE-4BB5-4058-AC54-0AC9E5EF3C8EQ35682709-4BA7E7E5-A684-472F-9A15-7B2712E81E11Q35804192-33D1FB58-1920-4C65-B0E2-FCC47BF93C0CQ35859675-9FC94790-FBEE-4BB2-82CF-43DF316ADFB8Q35874030-F9AFF4DF-BB2D-483E-89D4-DBBB2CCB0FB3Q35962455-034AD814-B916-4A78-A33B-DDA2DB90E336Q36008558-211A0949-9893-4F35-9CF0-3F4064A02D49Q36202050-773EEBF6-F780-4D39-B30A-F974F1353137
P50
subject
description
American oncologist
@en
oncolojiste american
@lfn
oncólogo estadounidense
@es
oncólogu estauxunidense (1934–2014)
@ast
usona onkologo
@eo
عالم أورام من الولايات المتحدة الأمريكية
@ar
name
Donald Lee Morton
@da
Donald Lee Morton
@fo
Donald Lee Morton
@is
Donald Lee Morton
@kl
Donald Lee Morton
@nb
Donald Lee Morton
@nl
Donald Lee Morton
@nn
Donald Lee Morton
@sv
Donald Morton
@ca
Donald Morton
@cy
type
label
Donald Lee Morton
@da
Donald Lee Morton
@fo
Donald Lee Morton
@is
Donald Lee Morton
@kl
Donald Lee Morton
@nb
Donald Lee Morton
@nl
Donald Lee Morton
@nn
Donald Lee Morton
@sv
Donald Morton
@ca
Donald Morton
@cy
altLabel
Donald L Morton
@da
Donald L Morton
@de
Donald L Morton
@en
Donald L. Morton
@en
prefLabel
Donald Lee Morton
@da
Donald Lee Morton
@fo
Donald Lee Morton
@is
Donald Lee Morton
@kl
Donald Lee Morton
@nb
Donald Lee Morton
@nl
Donald Lee Morton
@nn
Donald Lee Morton
@sv
Donald Morton
@ca
Donald Morton
@cy
P1006
P214
P244
P268
P269
P1006
P106
P19
P20
P21
P213
0000 0001 1785 190X
P214
P244
P268
P269
P31
P569
1934-09-12T00:00:00Z
P570
2014-01-10T00:00:00Z
P734
P735
P7859
lccn-n81098759